Schedule 13D ownership disclosure
NEWAMSTERDAM PHARMA COMPANY
Ordinary Shares, Nominal value 0.12 per share · CUSIP: N62509109
Event date: 2025-08-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Forbion Capital Fund IV Cooperatief U.A.Reported CIK 0001823747
Shares: 5,930,781 · Class: 5.3%
- Forbion IV Management B.V.
Shares: 5,930,781 · Class: 5.3%
- Forbion Growth Opportunities Fund I Cooperatief U.A.
Shares: 4,648,025 · Class: 4.1%
- Forbion Growth Management B.V.
Shares: 4,648,025 · Class: 4.1%
- ForGrowth NAP B.V.
Shares: 10,578,806 · Class: 9.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-107390
- Form type
- SCHEDULE 13D/A
- Filer
- Forbion Capital Fund IV Cooperatief U.A.
- CIK
- CIK 1823747
- Filed
- Aug 12, 2025
- Reporting period
- Aug 08, 2025
- Description
- Schedule 13D beneficial ownership